Fremman Capital Acquires Majority Stake in DIESSE Diagnostica Senese
January 27, 2025
Fremman Capital has acquired a majority stake in Italian In Vitro Diagnostics (IVD) company DIESSE Diagnostica Senese from ARCHIMED's MED II. DIESSE, headquartered in Monteriggioni (Siena), Italy, operates a new biotech campus and ~230 employees and will continue to be led by its management team which retains a meaningful minority stake; Fremman plans to further internationalize and grow the business.
- Buyers
- Fremman Capital
- Targets
- DIESSE Diagnostica Senese
- Sellers
- ARCHIMED (MED II)
- Industry
- Medical Devices
- Location
- Tuscany, Italy
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.